Isolation, Characterization and Chemical Synthesis of Large Spectrum Antimicrobial Cyclic Dipeptide (l-leu-l-pro) from Streptomyces misionensis V16R3Y1 Bacteria Extracts. A Novel 1H NMR Metabolomic Approach
Authors:
- Ilhem SaadouliIlhem Saadouli
- Imène Zendah El EuchImène Zendah El Euch
- Emna TrabelsiEmna Trabelsi
- Amor MosbahAmor Mosbah
- Alaeddine RedissiAlaeddine Redissi
- Raoudha FerjaniRaoudha Ferjani
- Imene FhoulaImene Fhoula
- Ameur CherifAmeur Cherif
- Jean-Marc SabatierJean-Marc Sabatier
- Norbert SewaldNorbert Sewald
- Hadda-Imene OuzariHadda-Imene Ouzari
Open Access
- 21 May 2020
- journal article
- research article
- Published by MDPI AG in Antibiotics
- Vol. 9 (5) , 270
Abstract
Streptomyces is the most frequently described genus of Actinomycetes, a producer of biologically active secondary metabolites. Indeed, the Streptomyces species produces about 70% of antibiotics and 60% of antifungal molecules used in agriculture. Our study was carried out with the goal of isolating and identifying antimicrobial secondary metabolites from Streptomyces misionensis V16R3Y1 isolated from the date palm rhizosphere (southern Tunisia). This strain presented a broad range of antifungal activity against Fusarium oxysporum, Aspergillus flavus, Penicillium expansum, Aspergillus niger, Candida albicans, Candida metapsilosis, and Candida parapsilosis and antibacterial activity against human pathogenic bacteria, including Escherichia fergusonii, Staphylococcus aureus, Salmonella enterica, Enterococcus faecalis, Bacillus cereus and Pseudomonas aeruginosa. The purification procedure entailed ethyl acetate extract, silica gel column, and thin layer chromatography. Based on 1H NMR metabolomic procedure application, also supported by the GC-MS analysis, cyclic dipeptide (l-Leucyl-l-Proline) was identified as the major compound in the bioactive fraction. In order to confirm the identity of the active compound and to have a large quantity thereof, a chemical synthesis of the cyclic dipeptide was performed. The synthetic compound was obtained with a very good yield (50%) and presented almost the same effect compared to the extracted fraction. This study indicates for the first time that Streptomyces misionensis V16R3Y1 exhibits a broad spectrum of antimicrobial activities, produced cyclic dipeptide (l-Leucyl-l-Proline) and might have potential use as a natural agent for pharmaceutical and agri-food applications.Keywords
Funding Information
- the Tunisian Ministry of Higher Education and Scientific Research (LR03ES03)
- German Academic Exchange Service (DAAD) (ID57166072)
This publication has 34 references indexed in Scilit:
- Biologically active secondary metabolites from ActinomycetesOpen Life Sciences, 2012
- Anti-inflammatory Principles from Cordyceps sinensisJournal of Natural Products, 2011
- New and Unexpected Insights into the Modulation of LuxR-Type Quorum Sensing by Cyclic DipeptidesACS Chemical Biology, 2009
- Microbial drug discovery: 80 years of progressThe Journal of Antibiotics, 2009
- Quantitative 1H NMR metabolomics reveals extensive metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell culturesBMC Plant Biology, 2008
- Targeted Profiling: Quantitative Analysis of 1H NMR Metabolomics DataAnalytical Chemistry, 2006
- Bioactive Microbial MetabolitesThe Journal of Antibiotics, 2005
- Cyclo(l-Leucyl-l-Prolyl) Produced byAchromobacter xylosoxidansInhibits Aflatoxin Production byAspergillus parasiticusApplied and Environmental Microbiology, 2004
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Isolation of L-Leucyl-L-proline Anhydride from Microbiological FermentationsJournal of the American Chemical Society, 1951